Cue Biopharma
100 hedge funds and large institutions have $393M invested in Cue Biopharma in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 39 increasing their positions, 18 reducing their positions, and 7 closing their positions.
Holders
100
Holders Change
+26
Holders Change %
+35.14%
% of All Funds
2.06%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
33
Increased
39
Reduced
18
Closed
7
Calls
$1.29M
Puts
$1.53M
Net Calls
-$235K
Net Calls Change
+$208K
Top Buyers
| 1 |
WP
1
Woodline Partners
San Francisco,
California
|
$16.2M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$25.2M |
| 3 |
3
BlackRock
New York
|
$47.3M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$32.8M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$6.69M |
